Loading... Please wait...
EUR
- Home
- Antibodies
- Biosimilar Antibodies
Biosimilar Antibodies
Biosimilar Antibodies
Validated for Therapeutic Research
Our Biosimilar Range
Why choose Biosimilar Antibodies?
- Cost-effective and reliable alternatives to reference biologics.
- Validated for diverse applications, including ELISAs, flow cytometry, and Western blotting.
- Suitable for biophysical characterization (SPR) and immunohistochemistry (IHC).
- Proven functionality in blocking, neutralization, co-stimulation, and depletion assays.
Testimonials & Partners
"I ordered from AssayGenie for the first time and would like to share my satisfied impression. The article (Bevacizumab; IVMB0232) was used as a positive control and works excellently in Biacore SPR measurements and VEGF bioassay"
- G. Carsten, Fraunhofer (2024)
cGMP & ISO Certification
Quality is at the core of everything we do.
Manufactured in state-of-the-art facilities, our products meet the highest standards, including current Good Manufacturing Practicies) cGMP, ISO 9001:2015, and ISO 13485:2016 certifications. These ensure consistent quality, customer-focused innovation, and reliable performance in every batch.
Biosimilar Production
Biosimilar Antibody Product Data
VivoGenie Biosimilars
VivoGenie Biosimilars
With low endotoxin levels (≤1.0 EU/mg) and minimal aggregation (≥95% monomer verified by SEC), they are ideal for sensitive applications. Formulated in sterile PBS (pH 7.2) without preservatives, stabilizers, or carrier proteins.
Reference Biosimilars
Conjugated Biosimilars
Meet Some of the Genie Team!
At Assay Genie, we're here to help every step of the way. Whether you need guidance choosing the right product, updates on your order, or expert support after your purchase, we've got you covered.
Colm PhD, CEO
Sean PhD, CSO
Shane MSc, Sales Manager
Beatriz, Logistics
David PhD, Partner Manager
Marina PhD, Tech Support
Joe MSc, Sales
Miren PhD, Product Manager
Zac MSc, Operations Manager
Natalia PhD, Tech Support
José MSc, Development Manager
FAQs & Citations
- Preclinical drug screening
- Assay development and validation (e.g., ELISA, Western Blot, Flow Cytometry)
- Mechanism of action studies
- Comparative studies against reference biologics
Product | Author | Citation |
|---|---|---|
Bikoriman et al. | ||
Leane et al. | ||
Rohani et al. | ||
Calvo et al. | ||
Turley et al. | ||
Wang et al. |
Biosimilar Resources - Blogs & Podcast Episodes
What Are Oligodendrocytes? Functions, Markers & Disease LinksOligodendrocytes are pivotal CNS cells, integral for myelin formation and nerve function, with implications in various neurological disorders.Key TakeawaysOligodendrocytes are specialized glial cells in the central nervous system (CNS), crucial for myelinating axons, enhancing nerve signal [...]
Quick Facts About EnavatuzumabWhat is Enavatuzumab?Enavatuzumab is a monoclonal antibody targeting the TWEAK receptor (Fn14), pivotal in tumor growth and immune regulation.What is the mechanism of action for Enavatuzumab?Enavatuzumab binds to Fn14, inhibiting signaling pathways that promote tumor cell proliferation and survival while [...]
Quick Facts About SiltuximabWhat is Siltuximab?Siltuximab is a monoclonal antibody targeting interleukin-6 (IL-6), a cytokine involved in inflammation and immune regulation.What is the mechanism of action for Siltuximab?Siltuximab binds to IL-6, preventing it from interacting with its receptor and mitigating downstream pro-inflammatory signaling.What [...]
Related Products
Additional Resourcers
